Methenamine hippurate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methenamine hippurate and what is the scope of patent protection?
Methenamine hippurate
is the generic ingredient in three branded drugs marketed by Esjay Pharma, Aurobindo Pharma Ltd, Impax Labs Inc, Ingenus Pharms Llc, Jubilant Cadista, Micro Labs, Zydus Lifesciences, and Quagen, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for methenamine hippurate. Twelve suppliers are listed for this compound.
Summary for methenamine hippurate
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Master File Entries: | 10 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 9 |
| Patent Applications: | 3,228 |
| Drug Prices: | Drug price trends for methenamine hippurate |
| What excipients (inactive ingredients) are in methenamine hippurate? | methenamine hippurate excipients list |
| DailyMed Link: | methenamine hippurate at DailyMed |
Recent Clinical Trials for methenamine hippurate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University College, London | PHASE2 |
| University Hospitals of North Midlands NHS Trust | EARLY_PHASE1 |
| Women and Infants Hospital of Rhode Island | PHASE4 |
Medical Subject Heading (MeSH) Categories for methenamine hippurate
Anatomical Therapeutic Chemical (ATC) Classes for methenamine hippurate
US Patents and Regulatory Information for methenamine hippurate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 205661-001 | Jul 5, 2016 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Jubilant Cadista | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 217675-001 | Dec 1, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Esjay Pharma | HIPREX | methenamine hippurate | TABLET;ORAL | 017681-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Micro Labs | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 212172-001 | Aug 1, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Quagen | UREX | methenamine hippurate | TABLET;ORAL | 016151-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ingenus Pharms Llc | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 210068-001 | Nov 27, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
